International Journal of Neonatal Screening Receives an Updated Impact Factor of 4.0 and CiteScore of 6.7

We are pleased to share that the International Journal of Neonatal Screening (IJNS, ISSN: 2409-515X) was awarded an increased Impact Factor of 4.0 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. IJNS ranks in Q1 (12 among 186 titles) in the “Pediatrics” category and Q1 (40 among 191 titles) in the “Genetics and Heredity” category.

Additionally, according to data released by Scopus (Elsevier), IJNS received an updated CiteScore™ of 6.7, an increase of 34% compared with the 2022 metric.

IJNS’ CiteScore ranks as follows:

• Q1 (32 out of 330 journals) in the “Pediatrics, Perinatology and Child Health” category;
• Q1 (25 out of 209 journals) in the “Obstetrics and Gynecology” category;
• Q1 (4 out of 29 journals) in the “Immunology and Microbiology (miscellaneous)” category.

For further statistics, please visit https://www.mdpi.com/journal/ijns/stats. For more information about MDPI flagship journals' citation metrics, please see here.

At MDPI our mission is simple yet powerful, we strive every day to make scientific research freely accessible to everyone, everywhere. With over 3.5 million authors choosing MDPI, we have established ourselves as a key player driving the open access initiative.

Our journals have received over 13 million citations in the Web of Science, making us the most cited open access publisher. With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services.

IJNS Editorial Office